The scientist’s investigation covers issues in Molecular biology, Immunology, Inflammation, Signal transduction and Gene expression. His Molecular biology research is multidisciplinary, incorporating perspectives in I-Kappa-B Kinase, Chromatin immunoprecipitation, Transcription factor, Regulation of gene expression and Kinase. His Immunology study combines topics from a wide range of disciplines, such as Disease and Intestinal epithelium.
His Inflammation research includes themes of Intestinal mucosa and Inflammatory bowel disease. His Inflammatory bowel disease research is multidisciplinary, incorporating elements of Azoxymethane and Microbiology. His Signal transduction study is focused on Cell biology in general.
Christian Jobin focuses on Immunology, Inflammation, Colitis, Microbiome and Molecular biology. His Immunology research integrates issues from Cancer, Colorectal cancer and Intestinal mucosa. The study incorporates disciplines such as Tumor necrosis factor alpha, Endocrinology and Cancer research in addition to Inflammation.
His studies deal with areas such as Interleukin 10, Campylobacter jejuni, Inflammatory bowel disease and Microbiology as well as Colitis. His study in Microbiome is interdisciplinary in nature, drawing from both Gut flora, Computational biology and Disease. His work is dedicated to discovering how Molecular biology, Signal transduction are connected with Phosphorylation and NFKB1 and other disciplines.
His primary areas of study are Cancer research, Colorectal cancer, Microbiome, Microbiology and Inflammation. Colorectal cancer is a subfield of Cancer that Christian Jobin explores. His Microbiome study integrates concerns from other disciplines, such as Computational biology and Disease.
His Microbiology research is multidisciplinary, incorporating perspectives in Enterobacteriaceae, Pathogenesis and Bacteria. His research integrates issues of Tumor necrosis factor alpha, Bacterial adhesin, Colitis and Gene in his study of Inflammation. Immune system is a subfield of Immunology that Christian Jobin studies.
His scientific interests lie mostly in Microbiome, Microbiology, Colorectal cancer, Disease and Inflammation. His study in the fields of Human microbiome under the domain of Microbiome overlaps with other disciplines such as Amniotic fluid. The various areas that Christian Jobin examines in his Microbiology study include Transcriptome, Gene expression, Carcinogenesis, Fibroblast and Interleukin 10.
His Colorectal cancer research includes elements of Clostridium difficile, Biofilm, Carcinogen, Immunology and Transplantation. His Carcinogen research includes themes of Necrosis, Human colon, Cancer research and Tumor necrosis factor alpha. His Inflammation research is multidisciplinary, relying on both Colitis, Bacteria, Enterobacteriaceae, Escherichia coli and Wild type.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
Janelle C. Arthur;Ernesto Perez-Chanona;Marcus Mühlbauer;Sarah Tomkovich.
The microbiome and cancer
Robert F. Schwabe;Christian Jobin.
Nature Reviews Cancer (2013)
Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity.
C Jobin;C A Bradham;M P Russo;B Juma.
Journal of Immunology (1999)
Toll-Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells
Yong-Han Paik;Yong-Han Paik;Robert F. Schwabe;Ramón Bataller;Maria P. Russo.
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Irving C. Allen;Erin McElvania Tekippe;Rita Marie T Woodford;Joshua M. Uronis.
Journal of Experimental Medicine (2010)
High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse
Shengli Ding;Michael M. Chi;Brooks P. Scull;Rachael Rigby.
PLOS ONE (2010)
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme
Bret D. Wallace;Hongwei Wang;Kimberly T. Lane;John E. Scott.
The IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Christian Jobin;R. Balfour Sartor.
American Journal of Physiology-cell Physiology (2000)
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility
Joshua M. Uronis;Marcus Mühlbauer;Hans H. Herfarth;Tara C. Rubinas.
PLOS ONE (2009)
NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling
Irving C. Allen;Justin E. Wilson;Monika Schneider;John D. Lich.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: